In the News

<< Back

2019

May 2019

Taking a Drug to Market “Is a Marathon, Not a Sprint”

2018

July 2018

Allergan and Molecular Partners release positive Phase III data on AMD drug

July 2018

In two PhIII wins for Allergan/Molecular Partners, wet AMD drug shows non-inferiority to Lucentis

July 2018

UPDATE 1-Allergan, Molecular Partners eye drug meets main goal in two studies

April 2018

AstraZeneca deal shows promise for Molecular Partners’ lung cancer therapy

April 2018

Molecular Partners gets AZ support for lung cancer trial

February 2018

Allergan exercises third option for Molecule Partners’ DARPin products

2017

October 2017

DARPins: an eye-opening new biologic therapy

2015

July 2015

Allergan goes full speed ahead with Molecular Partners’ Darpin AMD program